Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for HIVE. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: HIVE is a Strong Sell candidate.
HIVE stock price ended at $0.068600 on 火曜日, after dropping 21.52%
On May 05, 2026 00:00, the price of HIVE fell by 21.52%, dropping from $0.059705 to $0.068600 with 24h trading volume reaching $18.7M HIVE.